Le Zhang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis.
Journal: Clinical rheumatology
Published: March 07, 2023
Performance of LTBI Screening in Patients with Rheumatic Diseases Using Two Different Interferon-Gamma Releasing Assays.
Journal: Frontiers in bioscience (Landmark edition)
Published: June 13, 2022
Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World.
Journal: Journal of inflammation research
Published: September 17, 2020
Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China.
Journal: International journal of clinical pharmacy
Published: December 24, 2018
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram.
Journal: Patient preference and adherence
Published: September 22, 2018
Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China.
Journal: BMC health services research
Published: September 10, 2018
Treatment adherence and disease burden of individuals with rheumatic diseases admitted as outpatients to a large rheumatology center in Shanghai, China.
Journal: Patient preference and adherence
Published: October 28, 2017
GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Journal: Experimental cell research
Published: April 12, 2017
WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Journal: International journal of oncology
Published: November 18, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026